While the implementation of a ceiling price for the sale of Covid-19 vaccines Sinovac and Sinopharm is a good move to promote vaccine equity, it may negatively impact the health industry, the Association of Private Hospitals Malaysia (APHM) says.

In a statement yesterday, APHM president Dr Kuljit Singh (above) urged the government to consider the financial implications of the ceiling price upon health practitioners who had already bought the vaccines in bulk at a higher cost...